• Featured Product
  • KD/KO Validated

NAT10 Rekombinanter Antikörper

NAT10 Rekombinant Antikörper für WB, IF/ICC, IP, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IF/ICC, IP, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

5B9

Kat-Nr. : 82585-1-PBS

Synonyme

N acetyltransferase 10, KIAA1709, EC:2.3.1.-, ALP, 5B9



Geprüfte Anwendungen

Produktinformation

82585-1-PBS bindet in WB, IF/ICC, IP, Indirect ELISA NAT10 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen NAT10 fusion protein Ag4184
Vollständiger Name N-acetyltransferase 10 (GCN5-related)
Berechnetes Molekulargewicht 1025 aa, 116 kDa
Beobachtetes Molekulargewicht 116 kDa
GenBank-ZugangsnummerBC035558
Gene symbol NAT10
Gene ID (NCBI) 55226
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

NAT10 (N-acetyltransferase 10) is a nucleolar protein that is involved in regulation of telomerase activity, DNA damage response, and cytokinesis. It also plays a role in maintaining nuclear shape. Inhibition of NAT10 has been reported to rescue the misshapen nuclei in laminopathic cells via microtubule reorganization. The specificity of this antibody has been tested by siRNA (PMID: 24786082). NAT10 regulates mitotic cell fate by acetylating Eg5. NAT10 depletion results in multinuclear giant cells, which is the hallmark of mitotic catastrophe (PMID: 35210604). NAT10 plays a crucial role in carcinogenesis through influencing EMT, hypoxia, ribosomal biogenesis and overall, promoting translational efficiency. Recently, we reported that treating cancer cells with Remodelin, a small molecule inhibitor of NAT10, causes alteration in global lipid metabolism (PMID: 36149760).